Study of Womens Experience Using Contrast-enhanced Spectral Mammography CESM for Breast Cancer Screening Compared to Standard Mammograms

What this Trial Is About

Researchers are evaluating how well women may choose to use Contrast-enhanced Spectral Mammography CESM as their yearly breast cancer screening compared to the standard 2-D or 3-D mammogram. This study focuses on women with heterogeneous or dense breast tissue reported on a previous mammogram and who are not at high risk for breast cancer. The study aims to understand patient experiences and decision-making factors such as age, education, and lifetime risk in adopting CESM screening. The study involves 210 women who will undergo a screening CESM exam, which includes an iodine-based contrast injection followed by two images to detect areas of increased blood flow potentially indicating cancer. The CESM exam will replace their usual annual breast screening mammogram. Participants will complete questionnaires before and after the CESM exam to assess their attitudes, concerns about contrast use, and past mammogram experiences. Participants will be involved for approximately 16 months, during which researchers will evaluate patient experiences related to CESM screening. Surveys will assess willingness to undergo CESM and its association with demographic and risk factors. Abnormal findings will be managed independently. This study includes monitoring patient feedback and learning how CESM may be integrated into routine breast cancer screening for women with dense breast tissue.

Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening